Sign in

CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Vor Biopharma Inc.

Sign in to watch
Ticker
VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
811591163
Phone
617-655-6580
Business address
500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
  1. SCHEDULE 13D/A Stake Beneficial Ownership Report
  2. 4 Open-market sale 10% owner sold 98,387 shares at an average $36.12 ($3,553,499)
  3. SCHEDULE 13D/A Stake Beneficial Ownership Report
  4. 4 Open-market sale 10% owner sold 41,752 shares at an average $39.43 ($1,646,237)
  5. UPLOAD Other SEC-generated Letter
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. S-3 Offering Registration Statement
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. 4 Derivatives Options or other derivatives
  12. SCHEDULE 13D/A Stake Beneficial Ownership Report
  13. 4 Open-market sale 10% owner sold 447,278 shares at $1.54 ($688,853)
  14. 8-K Event Shareholder rights changed · Other events
  15. 4 Open-market sale 10% owner sold 984,805 shares at an average $1.73 ($1,703,971)
  16. SCHEDULE 13D/A Stake Beneficial Ownership Report
  17. 4 Open-market sale 10% owner sold 1,263,647 shares at an average $1.95 ($2,457,975)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. SCHEDULE 13D/A Stake Beneficial Ownership Report

Page 7 of 24 · 464 filings